Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs

This publication has 17 references indexed in Scilit:

• Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis.
  Journal of Clinical Investigation, 1986
• Cholecystokinin Antagonists
  Hormone and Metabolic Research, 1986
• A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus
  Science, 1985
• Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide
  Gastroenterology, 1985
• Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog
  Regulatory Peptides, 1984
• Radioimmunoassay of cholecystokinin
  Digestive Diseases and Sciences, 1983
• Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.
  Proceedings of the National Academy of Sciences, 1981
• The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog
  Gastroenterology, 1981
• Release of Pancreatic and Gastric Somatostatin-Like Immunoreactivity in Response to the Octapeptide of Cholecystokinin, Secretin Gastric Inhibitory Polypeptide, and Gastrin-17 in Dogs*
  Endocrinology, 1980
• Gastrin-related peptides as stimulants of pancreatic and gastric secretion
  American Journal of Physiology-Legacy Content, 1969